Rayner
Elodie Rottier has a diverse work experience spanning various roles in supply chain and customer service. Elodie is currently working at Rayner as the Supply Chain and Customer Service Director since April 2022. Prior to this, they served as the Head of Supply Chain and Customer Services at Rayner from December 2020 to May 2022. Before joining Rayner, Elodie worked as a Supply Chain Manager at the same company from January 2019 to December 2020. Elodie started their career at Rayner as a Supply Chain Planner from October 2017 to December 2018.
Before joining Rayner, Elodie worked at GlaxoSmithKline Pharma GmbH as a Supply Planning Manager from November 2016 to October 2017.
Elodie's extensive work experience also includes roles at Kimberly-Clark. Elodie served as the EMEA Procurement Manager from May 2015 to April 2016. Prior to this, they were the Strategic Planning Manager from April 2009 to April 2015. Elodie started their career at Kimberly-Clark as a Tactical Planner from October 2003 to March 2009 and as an Accounts Payable from October 2002 to October 2003.
Elodie Rottier completed their Masters Degree in Business Economics from the Université de Caen, Normandie, France, from 1996 to 2000. Elodie then pursued a Post-graduate Degree in Production Management at the IAE de Caen, Normandie, France, from 2001 to 2002. It is not specified when they obtained the Post-graduate Degree in Production Management.
This person is not in any teams
This person is not in any offices
Rayner
5 followers
Rayner designs and manufactures intraocular lenses and proprietary injection devices for use in cataract surgery. When Sir Harold Ridley designed the world’s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention.With more than 65 years of continuous growth and experience, we remain at the forefront of innovation. Weare focused on providing the best IOLs for clinicians and patients and are driven by science to improve patient outcomes and safety.Primary IOLs Our FDA-approved C-flex aspheric (aberration-neutral) monofocal IOL, as well as our toric and multifocal IOL families are now complemented by the RayOne fully preloaded monofocal IOL injection system. Supplementary IOLsDesigned to be implanted in the ciliary sulcus, Rayner Sulcoflex Pseudophakic Supplementary IOLs are available as aspheric, toric, multifocal and multifocal lenses, and offer a reversible solution for correcting residual post-operative refractive errors following the implantation of a conventional IOL in the capsular bag.OVDsOur Ophteis range offers a full spectrum of OVDs from dispersive to cohesive, enabling surgeons to select the OVD best suited to each specific cataract procedure. Ophteis FR Pro with sorbitol -- designed to deliver a new level of corneal endothelial protection from phaco induced trauma -- is the flagship product of Rayner’s ‘Ophteis’ OVD suite. PharmaceuticalsAlthough the intraocular lens plays a leading role in the visual outcomes of cataract and refractive surgery, the pharmaceuticals that manage the tear film and inflammation are critical to the end result. For that reason, Rayner recently acquired the business of Moorfields Pharmaceuticals. The acquisition will enable us to offer an even wider range of ophthalmic tools that aid and streamline the surgical process whilst remaining focused on the visual outcome for the patient.Rayner markets its IOL portfolio and related products worldwide through a network of distributors in over 80 countries with direct markets in UK, Germany & Austria, the United States of America, Italy and Spain. We have the world’s longest commercial history of IOL design and manufacturing and have worked with cataract surgeons for longer than anyone else.In 2016, Rayner transferred its global headquarters to a brand new state of the art manufacturing plant, which has dramatically increased the company’s production capacity.